Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer - Related Studies

Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer

This study has been completed.

Study NCT00078494. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Nasopharyngeal Neoplasms

2	More general conditions related to this trial
		Head and Neck Neoplasms
		Nasopharyngeal Diseases
		Neoplasms
		Neoplasms by Site
		Otorhinolaryngologic Diseases
		Otorhinolaryngologic Neoplasms
		Pharyngeal Diseases
		Pharyngeal Neoplasms
		Stomatognathic Diseases

3	Interventions listed in this trial
		EBV-LMP-2

4	Sponsors listed in this trial
		National Institutes of Health Clinical Center (CC)